Cara Therapeutics
CARA
#10490
Rank
A$11.27 M
Marketcap
A$7.40
Share price
-2.56%
Change (1 day)
4.94%
Change (1 year)

Market capitalization of Cara Therapeutics (CARA)

Last known market cap: A$11.27 Million

As of April 2026 Cara Therapeutics has a market cap of A$11.27 Million. This makes Cara Therapeutics the world's 10490th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cara Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$11.27 M-6.87%
2025A$12.1 M-63.68%
2024A$33.33 M-43.89%
2023A$59.41 M-92.99%
2022A$0.84 B-5.58%
2021A$0.89 B-8.4%
2020A$0.98 B-8.79%
2019A$1.07 B47.3%
2018A$0.72 B42.75%
2017A$0.51 B45.4%
2016A$0.35 B-44.26%
2015A$0.63 B127.08%
2014A$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$754.16 B 6,687,559.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$213.07 B 1,889,343.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
A$0.01 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
A$0.17 B 1,419.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
A$0.63 B 5,558.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.14 M-89.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
A$20.27 M 79.75%๐Ÿ‡บ๐Ÿ‡ธ USA